Celularity Inc
CELUW
17 hedge funds and large institutions have $159K invested in Celularity Inc in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
140% more capital invested
Capital invested by funds: $66.1K → $159K (+$92.8K)
0.31% less ownership
Funds ownership: 2.46% → 2.15% (-0.31%)
15% less funds holding
Funds holding: 20 → 17 (-3)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$663 |
| 2 |
CS
Clear Street
New York
|
+$208 |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$15 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$7.17K |
| 2 |
Walleye Capital
New York
|
-$860 |
| 3 |
TSS
Two Sigma Securities
New York
|
-$367 |
| 4 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$350 |
| 5 |
GS
GTS Securities
New York
|
-$280 |
CELUW Hedge Fund Activity: Q4 2023 in Review
17 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Celularity Inc (CELUW) for Q4 2023, worth a combined $159K — up 140% from $66.1K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CELUW and 2 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, opening a new position worth an estimated $663. The largest seller was Ionic Capital Management, exiting entirely with an estimated $7.17K sold.
- 17 institutional investors held Celularity Inc (CELUW) as of Q4 2023, down from 20 in Q3 2023.
- Funds reported $159K of Celularity Inc stock for Q4 2023, up 140% quarter-over-quarter.
- 2 funds opened new Celularity Inc positions in Q4 2023 and 5 closed out, a net change of -3 holders.
- The largest Celularity Inc buyer in Q4 2023 was UBS Group, an estimated $663 added.
- The largest Celularity Inc seller in Q4 2023 was Ionic Capital Management, an estimated $7.17K sold.
Based on aggregated 13F filings for Q4 2023.